Triplex-forming oligonucleotides with unexpected affinity for a nontargeted GA repeat sequence

Antisense and Nucleic Acid Drug Development

Volumn 7, Issue 2, 1997, Pages 125-130

  Beaulieu, Martin ^a   Barbeau, Benoît ^a   Rassart, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; OLIGODEOXYNUCLEOTIDE; PURINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA SEQUENCE; DRUG DNA BINDING; DRUG SPECIFICITY; ELECTROPHORETIC MOBILITY; EXON; GENE TARGETING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRIPLE HELIX;

EID: 0030972818     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1997.7.125     Document Type: Article

References (4)

1. BARBEAU, B., BERGERON, D., BEAULIEU, M., NADJEM, Z., and RASSART, E. (1996). Characterization of the human and mouse Fli-1 promoter regions. Biochim. Biophys. Acta 1307, 220-232.
2. DURLAND, R.H., KESSLER, D.J., GUNNELL, S., DUVIC, M., PETTITT, B.M., and HOGAN, M.E. (1991). Binding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry 30, 9246-9255.
3. FRANK-KAMENETSKII, M.D., and MIRKIN, S.M. (1995). Triplex DNA structures. Annu. Rev. Biochem. 64, 65-95.
4. WELLS, R.D., COLLIER, D.A., HANVEY, J.C., SHIMIZU, M., and WOHLRAB, F. (1988). The chemistry and biology of unusual DNA structures adopted by oligopurine/oligopyrimidine sequences. FASEB J. 2, 2939-2949.